Advertisement

Topics

Evidence mounts yet again against efficacy of common morning sickness pill

04:54 EST 18 Jan 2018 | Pharmafile

Evidence is mounting against the efficacy of the common morning sickness pill pyridoxine-doxylamine  (Diclegis, Diclectin), as new study data reveals that it may not actually aid the relief of nausea, and is leading some doctors to advise against prescribing the drug.

read more

Original Article: Evidence mounts yet again against efficacy of common morning sickness pill

NEXT ARTICLE

More From BioPortfolio on "Evidence mounts yet again against efficacy of common morning sickness pill"

Advertisement
Quick Search
Advertisement
Advertisement

 

Relevant Topic

Drug Discovery
Clinical Approvals Clinical Trials Drug Approvals Drug Delivery Drug Discovery Generics Drugs Prescription Drugs In the fields of medicine, biotechnology and pharmacology, drug discovery is the process by which drugs are dis...